Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with self-collected nasal swab versus professional-collected nasopharyngeal swab. Issue 4 (15th April 2021)

• Record Type: Journal Article
• Authors: Lindner, Andreas K.; Nikolai, Olga; Kausch, Franka; Wintel, Mia; Hommes, Franziska; Gertler, Maximilian; Krüger, Lisa J.; Gaeddert, Mary; Tobian, Frank; Lainati, Federica; Köppel, Lisa; Seybold, Joachim; Corman, Victor M.; Drosten, Christian; Hofmann, Jörg; Sacks, Jilian A.; Mockenhaupt, Frank P.; Denkinger, Claudia M.
• Is Part Of: European respiratory journal. Volume 57:Issue 4(2021)
• Publication Date: 2021-04-15
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.03961-2020
• Languages: English
• ISSNs: 0903-1936

Abstract

A number of antigen-detecting rapid diagnostic tests (Ag-RDTs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are now commercially available and can result in rapid decisions on patient care, isolation and contact tracing at the point of care [1]. Two Ag-RDTs using nasopharyngeal (NP) swab samples meet World Health Organization (WHO) targets and are now approved through the WHO Emergency Use Listing procedure [2–4]. Supervised nasal self-sampling is a reliable alternative to professional nasopharyngeal sampling using a WHO-listed SARS-CoV-2 antigen-detecting rapid test. Self-sampling and potentially patient self-testing may be a future use case. https://bit.ly/3mup0hS